Last updated: March 18, 2024
Sponsor: Augusto Vaglio
Overall Status: Active - Recruiting
Phase
N/A
Condition
Histiocytoma
Treatment
Presence of polymorphisms
Clinical Study ID
NCT06332183
ECDGWAS
Ages 1-99 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- ECD with histological confirmation of disease
Exclusion
Exclusion criteria:
- previously treated patients (for methylation and gene expression)
Study Design
Total Participants: 300
Treatment Group(s): 1
Primary Treatment: Presence of polymorphisms
Phase:
Study Start date:
July 17, 2019
Estimated Completion Date:
October 01, 2024
Connect with a study center
Hopital Pitié Salpetrière
Paris,
FranceActive - Recruiting
Meyer Children's Hospital IRCCS
Florence,
ItalyActive - Recruiting
IRCCS Ospedale San Raffaele
Milano,
ItalyActive - Recruiting
AOU Parma
Parma,
ItalyActive - Recruiting
Genetics Lab, CSIC
Granada,
SpainActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.